Literature DB >> 31240737

Analysis of the Qatari R336C cystathionine β-synthase protein in mice.

Sapna Gupta1, Lorena Gallego-Villar2, Liqun Wang1, Hyung-Ok Lee1, Gheyath Nasrallah3, Nader Al-Dewik4, Johannes Häberle5, Beat Thöny5, Henk J Blom6, Tawfeg Ben-Omran4, Warren D Kruger1.   

Abstract

Classical homocystinuria is a recessive inborn error of metabolism caused by mutations in the cystathionine beta-synthase (CBS) gene. The highest incidence of CBS deficiency in the world is found in the country of Qatar due to the combination of high rates of consanguinity and the presence of a founder mutation, c.1006C>T (p.R336C). This mutation does not respond to pyridoxine and is considered severe. Here we describe the creation of a mouse that is null for the mouse Cbs gene and expresses human p.R336C CBS from a zinc-inducible transgene (Tg-R336C Cbs -/- ). Zinc-treated Tg-R336C Cbs -/- mice have extreme elevation in both serum total homocysteine (tHcy) and liver tHcy compared with control transgenic mice. Both the steady-state protein levels and CBS enzyme activity levels in liver lysates from Tg-R336C Cbs -/- mice are significantly reduced compared to that found in Tg-hCBS Cbs -/- mice expressing wild-type human CBS. Treatment of Tg-R336C Cbs -/- mice with the proteasome inhibitor bortezomib results in stabilization of liver CBS protein and an increase in activity to levels found in corresponding Tg-hCBS Cbs -/- wild type mice. Surprisingly, serum tHcy did not fully correct even though liver enzyme activity was as high as control animals. This discrepancy is explained by in vitro enzymatic studies of mouse liver extracts showing that p.R336C causes reduced binding affinity for the substrate serine by almost 7-fold and significantly increased dependence on pyridoxal phosphate in the reaction buffer. These studies demonstrate that the p.R336C alteration effects both protein stability and substrate/cofactor binding.
© 2019 SSIEM.

Entities:  

Keywords:  homocysteine; inborn error; metabolism; methionine; missense mutation; mouse model

Year:  2019        PMID: 31240737      PMCID: PMC7336392          DOI: 10.1002/jimd.12140

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

1.  Mutations in the regulatory domain of cystathionine beta synthase can functionally suppress patient-derived mutations in cis.

Authors:  X Shan; R L Dunbrack; S A Christopher; W D Kruger
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

Review 2.  Cystathionine beta-synthase mutations in homocystinuria.

Authors:  J P Kraus; M Janosík; V Kozich; R Mandell; V Shih; M P Sperandeo; G Sebastio; R de Franchis; G Andria; L A Kluijtmans; H Blom; G H Boers; R B Gordon; P Kamoun; M Y Tsai; W D Kruger; H G Koch; T Ohura; M Gaustadnes
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

3.  Expression of mutant human cystathionine beta-synthase rescues neonatal lethality but not homocystinuria in a mouse model.

Authors:  Liqun Wang; Xulin Chen; Baiqing Tang; Xiang Hua; Andres Klein-Szanto; Warren D Kruger
Journal:  Hum Mol Genet       Date:  2005-06-22       Impact factor: 6.150

4.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors.

Authors:  Sapna Gupta; Liqun Wang; Janet Anderl; Michael J Slifker; Christopher Kirk; Warren D Kruger
Journal:  Hum Mutat       Date:  2013-05-13       Impact factor: 4.878

6.  Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice.

Authors:  R D Palmiter; E P Sandgren; D M Koeller; R L Brinster
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.

Authors:  Noriyuki Akahoshi; Chiho Kobayashi; Yasuki Ishizaki; Takashi Izumi; Toshiyuki Himi; Makoto Suematsu; Isao Ishii
Journal:  Hum Mol Genet       Date:  2008-03-25       Impact factor: 6.150

8.  Protein arginine hypomethylation in a mouse model of cystathionine β-synthase deficiency.

Authors:  Ruben Esse; Apolline Imbard; Cristina Florindo; Sapna Gupta; Eoin P Quinlivan; Mariska Davids; Tom Teerlink; Isabel Tavares de Almeida; Warren D Kruger; Henk J Blom; Rita Castro
Journal:  FASEB J       Date:  2014-02-14       Impact factor: 5.191

Review 9.  Adapting proteostasis for disease intervention.

Authors:  William E Balch; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly
Journal:  Science       Date:  2008-02-15       Impact factor: 63.714

10.  Cystathionine beta-synthase p.S466L mutation causes hyperhomocysteinemia in mice.

Authors:  Sapna Gupta; Liqun Wang; Xiang Hua; Jakub Krijt; Viktor Kozich; Warren D Kruger
Journal:  Hum Mutat       Date:  2008-08       Impact factor: 4.878

View more
  2 in total

Review 1.  How to fix a broken protein: restoring function to mutant human cystathionine β-synthase.

Authors:  Warren D Kruger
Journal:  Hum Genet       Date:  2021-10-12       Impact factor: 5.881

Review 2.  The Spectrum of Mutations of Homocystinuria in the MENA Region.

Authors:  Duaa W Al-Sadeq; Gheyath K Nasrallah
Journal:  Genes (Basel)       Date:  2020-03-20       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.